NEW YORK, May 8, 2013 /PRNewswire/ -- Paradigm Spine LLC, a provider of innovative spinal implant technologies, announced today the launch of its new coflex® Solution patient-centric website (www.coflexsolution.com) to help provide patients with information related to the symptoms of Lumbar Spinal Stenosis and both non-surgical and surgical treatment options for the disease. The U.S. Food and Drug Administration granted Premarket Approval ("PMA") for coflex®, a minimally invasive, Motion Preserving Interlaminar Stabilization device that is the first and only alternative to fusion for the treatment of Moderate To Severe Stenosis With Or Without Back Pain in October, 2012.
"We are pleased to provide potential patients with an easy-to-use resource on how the coflex® device may be an option for treatment of Lumbar Spinal Stenosis. Our new coflex® Solution website provides easy-to-understand information about the disease and various treatment pathways, including a demonstration of how the coflex® device functions. The website also provides potential patients with access to further informational resources through our coflex® Solution hotline and trained surgeon locator," stated Marc Viscogliosi, Chairman & CEO of Paradigm Spine.
About Paradigm Spine LLC
Paradigm Spine LLC, founded by Viscogliosi Bros., LLC in 2004, is a privately held company focused on the design, development and marketing of solutions for the treatment of spinal conditions and diseases. The company's signature product is the coflex® Interlaminar Stabilization device, which has more than 18 years of clinical history with regulatory approval in more than 40 countries throughout 6 continents. For more information on Paradigm Spine LLC, please visit the company's website at www.paradigmspine.com.
Marc R. Viscogliosi, Chairman & CEO
(212) 367-7274, Ext. 2103
SOURCE Paradigm Spine LLC